We are live on ! Find out more
PRCT icon

Procept Biorobotics
PRCT

60 hedge funds and large institutions have $732M invested in Procept Biorobotics in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 6

17% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 23

3% more funds holding

Funds holding: 58 → 60 (+2)

3.29% more ownership

Funds ownership: 64.41% → 67.7% (+3.3%)

29% less capital invested

Capital invested by funds: $1.03B → $732M (-$295M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
27
Increased
19
Reduced
6
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DFO
Duquesne Family Office
New York
+$39.2M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.6M
3
BlackRock
BlackRock
New York
+$11.1M
4
Renaissance Technologies
Renaissance Technologies
New York
+$6.63M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.58M

Top Sellers

1
PA
Perceptive Advisors
New York
-$12.2M
2
O
OrbiMed
New York
-$5.15M
3
YRHAM
Yong Rong (HK) Asset Management
Hong Kong
-$4.85M
4
GGHC
Gilder Gagnon Howe & Co
New York
-$4.71M
5
Goldman Sachs
Goldman Sachs
New York
-$2.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
CI
1
CPMG Inc
Texas
$281M – – –
Viking Global Investors
2
Viking Global Investors
Connecticut
$123M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$93.6M +$18.6M +502,838 +15%
DFO
4
Duquesne Family Office
New York
$41.5M +$39.2M +1,060,435 +177%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$34.1M +$2.3M +62,087 +5%
PA
6
Perceptive Advisors
New York
$33.2M -$12.2M -328,705 -20%
JJ
7
Johnson & Johnson
New Jersey
$25.5M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$14.6M +$4.76M +128,780 +28%
Massachusetts Financial Services
9
Massachusetts Financial Services
Massachusetts
$13.4M +$4.62M +125,010 +30%
BlackRock
10
BlackRock
New York
$8.04M +$11.1M +301,305 +1,507%
PC
11
PointState Capital
New York
$6.77M -$152K -4,100 -1%
RI
12
RTW Investments
New York
$4.86M – – –
Renaissance Technologies
13
Renaissance Technologies
New York
$4.48M +$6.63M +179,300 New
BG
14
Bellevue Group
Switzerland
$4.34M +$875K +23,649 +16%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$4.01M +$5.58M +150,952 +1,636%
PVI
16
Pura Vida Investments
New York
$3.88M -$177K -4,786 -3%
Citadel Advisors
17
Citadel Advisors
Florida
$3.41M +$4.2M +113,439 +496%
YRHAM
18
Yong Rong (HK) Asset Management
Hong Kong
$3.28M -$4.85M -131,000 -50%
Marshall Wace
19
Marshall Wace
United Kingdom
$2.91M +$4.31M +116,493 New
AAA
20
Affinity Asset Advisors
New York
$2.5M +$794K +21,466 +27%
Millennium Management
21
Millennium Management
New York
$2.13M +$1.51M +40,724 +91%
State Street
22
State Street
Massachusetts
$2.12M +$3.14M +84,798 New
SV
23
Sturgeon Ventures
United Kingdom
$1.85M +$2.73M +73,856 New
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$1.76M +$2.6M +70,214 New
Northern Trust
25
Northern Trust
Illinois
$1.65M +$2.44M +66,061 New
1
2 3 4

PRCT Hedge Fund Activity: Q4 2021 in Review

60 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q4 2021, worth a combined $732M — down 29% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new PRCT positions and 23 closed out — a net gain of 4 holders — while 19 added to existing stakes and 6 trimmed.

The largest buyer was Duquesne Family Office, adding an estimated $39.2M. The largest seller was Perceptive Advisors, cutting an estimated $12.2M.

  • 60 institutional investors held Procept Biorobotics (PRCT) as of Q4 2021, up from 58 in Q3 2021.
  • Funds reported $732M of Procept Biorobotics stock for Q4 2021, down 29% quarter-over-quarter.
  • 27 funds opened new Procept Biorobotics positions in Q4 2021 and 23 closed out, a net change of +4 holders.
  • The largest Procept Biorobotics buyer in Q4 2021 was Duquesne Family Office, an estimated $39.2M added.
  • The largest Procept Biorobotics seller in Q4 2021 was Perceptive Advisors, an estimated $12.2M sold.

Based on aggregated 13F filings for Q4 2021.